
To help keep our community authentic, we're showing information about accounts on Linktree.
@SevenichLab has been a member of Linktree for 2 years and joined in August 2023. Resources sevenichlab has populated their site with include: • Prof. Dr. Lisa Sevenich | Universitätsklinikum Tübingen • Sevenich Lab: Hertie-Institut für klinische Hirnforschung • Dr. Lisa Sevenich - Georg-Speyer-Haus • Sevenich Lab on twitter (X) • Sevenich Lab on ResearchGate • Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis - Nature Cancer • Deep sequencing reveals heterogeneity of brain metastasis-associated macrophages and microglia and uncovers their cell type-specific functions within the tumor microenvironment • Cellular and Molecular Changes of Brain Metastases-Associated Myeloid Cells during Disease Progression and Therapeutic Response • The immune suppressive microenvironment affects efficacy of radio-immunotherapy in brain metastasis • Evaluating Magnetic Resonance Spectroscopy as a Tool for Monitoring Therapeutic Response of Whole Brain Radiotherapy in a Mouse Model for Breast-to-Brain Metastasis • Take my breath away: TAM-ing anti-cancer immunity in hypoxic niches • Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity • The Brain Pre-Metastatic Niche: Biological and Technical Advancements • TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man • Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis • Activation of Microglia and Macrophages in Neurodegenerative Diseases • Analyzing the Role of Proteases in Breast Cancer Progression and Metastasis Using Primary Cells from Transgenic Oncomice • Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer • Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers